EPMR-MA: Knowing and Remembering: Cognitive and Neural Influences of Familiarity on Recognition Memory in Early Alzheimer's Disease

Sponsor
Rennes University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT02492529
Collaborator
(none)
100
1
3
29.4
3.4

Study Details

Study Description

Brief Summary

Unrandomized, unblinded, monocentric comparative Functional Magnetic Resonance Imaging study.

Condition or Disease Intervention/Treatment Phase
  • Other: Neuropsychological tests
  • Device: A cranial MRI
  • Other: Experimental procedure
N/A

Detailed Description

Prospective functional Magnetic Resonance Imaging study involving a group of participants with Mild Cognitive Impairment due to AD and a control participants group matched for age, education level, verbal Intelligence Quotient as assessed through the French version of the National Adult Reading Test and income group following National Institute of Statistics and Economics Studies classification.

Study Design

Study Type:
Interventional
Actual Enrollment :
100 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Knowing and Remembering: Cognitive and Neural Influences of Familiarity on Recognition Memory in Early Alzheimer's Disease
Actual Study Start Date :
Jul 21, 2015
Actual Primary Completion Date :
Dec 31, 2017
Actual Study Completion Date :
Dec 31, 2017

Arms and Interventions

Arm Intervention/Treatment
Other: Healthy volunteers

60 old healthy volunteers (aged 25-75) will undergo an inclusion visit in order to check inclusion and non inclusion criteria. Then will be performed: Neuropsychological tests Experimental procedure

Other: Neuropsychological tests
Scales and tests to evaluate: Global cognitive performance Handedness Memory functions performance Gestural praxis functions performance Lexical and semantic functions performance Executive functions performance Memory disorders Way of life Mood

Other: Experimental procedure

Experimental: Patients with early Alzheimer disease

20 patients (aged 60-75) will undergo an inclusion visit in order to check inclusion and non inclusion criteria. Then will be performed: Neuropsychological tests Experimental procedure A cranial MRI

Other: Neuropsychological tests
Scales and tests to evaluate: Global cognitive performance Handedness Memory functions performance Gestural praxis functions performance Lexical and semantic functions performance Executive functions performance Memory disorders Way of life Mood

Device: A cranial MRI

Other: Experimental procedure

Experimental: Old healthy volunteers

20 healthy volunteers (aged 60-75) will undergo an inclusion visit in order to check inclusion and non inclusion criteria. Then will be performed: Neuropsychological tests Experimental procedure A cranial MRI

Other: Neuropsychological tests
Scales and tests to evaluate: Global cognitive performance Handedness Memory functions performance Gestural praxis functions performance Lexical and semantic functions performance Executive functions performance Memory disorders Way of life Mood

Device: A cranial MRI

Other: Experimental procedure

Outcome Measures

Primary Outcome Measures

  1. Improvement of recognition memory accuracy measures under the familiarity condition as compared with the novel condition in the AD-MCI group [3 months]

  2. Significant effect of the familiarity vs novelty condition on the pattern of % BOLD signal change in across the brain in the AD-MCI group [3 months]

Secondary Outcome Measures

  1. Significant group effect on the pattern of % BOLD signal change in across the brain [3 months]

  2. Predictive validity of the brain % BOLD signal change pattern for participants clinical status (i.e. controls vs. AD-MCI) [3 months]

  3. Significant interaction between the kind of familiarity condition (i.e. novel, experimental or pre-experimental) and the estimates of recognition memory processes efficiency (i.e. respective contributions of recollection and familiarity, % correct) [3 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

Volunteers (pilot phase)

  • Aged 25 - 75

  • French native speakers

  • Right-handed

  • Education level equal or superior to primary school leaving certificate

  • Free from any medical or psychiatric condition that may impact cognition

  • Having given written informed consent

Volunteers (experimental phase)

  • Aged 60 - 75

  • French native speakers

  • Right-handed

  • Education level equal or superior to primary school leaving certificate

  • Free from any medical or psychiatric condition that may impact cognition

  • Having given written informed consent

AD-MCI participants

  • Aged 60 - 75

  • French native speakers

  • Right-handed

  • Education level equal or superior to primary school leaving certificate

  • Fulfilling criteria for " AD-MCI " (Albert et al., 2011)

  • Have been seen in a memory medical center or in Memory Resources and Research Medical Center for cognitive symptoms

  • Free from any medical or psychiatric condition that may impact cognition

  • Able to understand and consent

  • Having given written informed consent

Exclusion Criteria:

MRI contraindications (all participants)

  • Claustrophobia

  • Wearing of any metal implant such as:

  • Heart pacemaker

  • Iron-magnetic surgical clips

  • Any metallic foreign body in the eye or brain

Other criteria (all participants)

  • Significant history of neurological or psychiatric disorders

  • Ongoing medication that may affect cognitive performances

  • Sensory deficit that may interfere with the experimental design (e.g. uncorrected visual impairment)

  • Lack of sufficient cooperation during the cognitive tasks

  • Persons under major legal protection and/or deprived of liberty

Other criteria (control participants)

  • Global cognitive impairment attested by Mattis Dementia Rating Scale or Mini-Mental State Examination, according to available normative data

Other criteria (AD-MCI participants)

  • 7 items modified Hachinski ischemic score > 2 (Hachinski et al., 2012)

  • Dementia (McKahn, et al., 2011)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre Hospitalier Universitaire Rennes France 35033

Sponsors and Collaborators

  • Rennes University Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Rennes University Hospital
ClinicalTrials.gov Identifier:
NCT02492529
Other Study ID Numbers:
  • 2014-A01123-44
  • 35RC14_9777_EPMR-MA
First Posted:
Jul 8, 2015
Last Update Posted:
Jan 23, 2018
Last Verified:
Jan 1, 2018
Keywords provided by Rennes University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 23, 2018